Cargando…
Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis
The outbreak of Coronavirus Disease 2019 (COVID-19) has been declared as a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO), which is being rapidly spread by the extremely spreadable and pathogenic 2019 novel coronavirus (2019-nCoV), also known as SARS-...
Autores principales: | Bhowmik, Deep, Nandi, Rajat, Prakash, Amresh, Kumar, Diwakar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955945/ https://www.ncbi.nlm.nih.gov/pubmed/33748510 http://dx.doi.org/10.1016/j.heliyon.2021.e06515 |
Ejemplares similares
-
Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches
por: Bhowmik, Deep, et al.
Publicado: (2020) -
Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach
por: Saha, Satabdi, et al.
Publicado: (2021) -
“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro)"
por: Bhowmik, Deep, et al.
Publicado: (2021) -
The Mechanism Study of Common Flavonoids on Antiglioma Based on Network Pharmacology and Molecular Docking
por: Li, Taiping, et al.
Publicado: (2022) -
An update on the 2019-nCoV outbreak
por: Ammad Ud Din, Mohammad, et al.
Publicado: (2020)